Trigonocephaly-short stature-developmental delay syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3369OMIM:314320Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Trigonocephaly-short stature-developmental delay syndrome (also known as Say-Meyer syndrome) is an extremely rare genetic condition characterized by a distinctive combination of craniofacial, skeletal, and neurodevelopmental abnormalities. The hallmark feature is trigonocephaly, a skull malformation caused by premature fusion (craniosynostosis) of the metopic suture, resulting in a triangular-shaped forehead. Affected individuals also present with short stature and developmental delay, including intellectual disability of variable severity. The syndrome affects multiple body systems. Craniofacial features may include a prominent or ridged metopic suture, hypotelorism (closely spaced eyes), and other facial dysmorphisms. Skeletal abnormalities beyond short stature can be present. Neurological involvement manifests as global developmental delay, with delays in motor and cognitive milestones. Additional features reported in some cases include microcephaly and other minor anomalies. This condition has been described in only a very small number of patients in the medical literature, making it one of the rarest recognized syndromes. Due to its extreme rarity, there is no specific treatment available. Management is supportive and symptomatic, potentially including surgical correction of craniosynostosis if clinically indicated, growth monitoring, and developmental support services such as early intervention programs, speech therapy, and special education. A multidisciplinary approach involving craniofacial surgeons, pediatric endocrinologists, neurologists, and developmental specialists is recommended.

Also known as:

Clinical phenotype terms— hover any for plain English:

Broad secondary alveolar ridgeHP:0000216Small anterior fontanelleHP:0000237Premature posterior fontanelle closureHP:0005494Metopic suture patent to nasal rootHP:0005495Fifth finger distal phalanx clinodactylyHP:0005769
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Trigonocephaly-short stature-developmental delay syndrome.

View clinical trials →

No actively recruiting trials found for Trigonocephaly-short stature-developmental delay syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Trigonocephaly-short stature-developmental delay syndrome community →

No specialists are currently listed for Trigonocephaly-short stature-developmental delay syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Trigonocephaly-short stature-developmental delay syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Trigonocephaly-short stature-developmental delay syndromeForum →

No community posts yet. Be the first to share your experience with Trigonocephaly-short stature-developmental delay syndrome.

Start the conversation →

Latest news about Trigonocephaly-short stature-developmental delay syndrome

No recent news articles for Trigonocephaly-short stature-developmental delay syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Trigonocephaly-short stature-developmental delay syndrome

What is Trigonocephaly-short stature-developmental delay syndrome?

Trigonocephaly-short stature-developmental delay syndrome (also known as Say-Meyer syndrome) is an extremely rare genetic condition characterized by a distinctive combination of craniofacial, skeletal, and neurodevelopmental abnormalities. The hallmark feature is trigonocephaly, a skull malformation caused by premature fusion (craniosynostosis) of the metopic suture, resulting in a triangular-shaped forehead. Affected individuals also present with short stature and developmental delay, including intellectual disability of variable severity. The syndrome affects multiple body systems. Craniofa

How is Trigonocephaly-short stature-developmental delay syndrome inherited?

Trigonocephaly-short stature-developmental delay syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Trigonocephaly-short stature-developmental delay syndrome typically begin?

Typical onset of Trigonocephaly-short stature-developmental delay syndrome is neonatal. Age of onset can vary across affected individuals.